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an integrated aspect of multidisciplinary
team research. Moreover, to address fun-
damental problems in medicine and biol-
ogy, there is no one tool that can provide
all the answers. Thus, in addition to devel-
oping specific technologies, a second set
of programs is envisioned, focusing on
bringing together topic- or disease-based
expertise with multiple structural method-
ologies to work on a key problem in med-
icine and biology. For these teams, an
emphasis would also be placed on devel-
oping approaches to foster integration of
the structural expertise and technologists
with functional analyses of the system
under investigation. The objective here is
to demonstrate the power of integration
by achieving successes in specific areas
of high biomedical relevance. This aspect
of the PSI would lead naturally to partner-
ships with disease-based institutes at
NIH.
How would this modified PSI operate?
The key feature is that rather than devel-
oping a small number of very large cen-
ters, the new PSI strategy would involve
a series of tightly coordinated smaller
groups, each with a specific focus that
feeds into the overall technology devel-
opment plan. These delocalized and
smaller-scale teams would be built
around institutional and regional groups
of investigators who can interact readily
on a daily basis. The smaller size and
larger number of research teams will pro-
vide for a much greater degree of flexibil-
ity and adaptability. In this scenario, there
has to be a very strong central organiza-
tional structure responsible for maintain-
ing a high degree of coordination of the
research efforts and facile exchange
between the various teams. This group
could be housed at one of the existing
PSI sites or on the NIH campus.
The NIGMS PSI is evolving and the time
is ripe to make key modifications in re-
sponse to new knowledge and the chang-
ing environment. Generating a consensus
across the structural biology community
and focusing on grand structural chal-
lenges will enhance the PSI and result in
high impact on the biomedical research
enterprise.
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DOI 10.1016/j.str.2007.12.001The genome sequencing revolution has
resulted in a dramatic increase in the de-
mand for structural information, a demand
that traditional structural biology is totally
unable to meet. The chance that a se-
quenced protein domain will have an
experimental structure is already near
0.1% and that ratio is falling fast. All over
the world, molecular and cell biologists
are staring in frustration at the sequences
of their proteins of interest, wishing they
had structure. In recognition of this,
a number of structural genomics projects,
the NIH Protein Structure Initiative (PSI) in
particular, have set out to maximize the
number of protein domains for which
structural information is available. Inher-
ent in the strategy is leverage of experi-
mental information through comparative
modeling of related structures.
There is no doubt that for some pur-
poses an experimental structure, or in-
deed awhole series of structures, is highly14 Structure 16, January 2008 ª2008 Elseviedesirable in order to obtain the necessary
understanding of the system of interest.
For example, if the goal is structure-based
drug design, an experimental high-resolu-
tion crystal structure of the protein and
relevant complexes is almost essential
(although even for this most demanding
application, there are a number of reports
of drug design on models, for example,
Becker et al., 2006). But such applications
are not in fact typical, and the output of
the PSI and other structural genomics
projects is aimed at a much broader set
of possible uses. To assess the utility of
its strategy, we must ask how useful the
models are to the full range of relevant
biologists.
The lowest resolution models, typically
produced by remote fold relationship rec-
ognition and not refined, have many er-
rors, but are nevertheless usually just
fine for such applications as recognizing
approximate domain boundaries (oftenr Ltd All rights reservedcritical for successful expression; Tress
et al., 2007), assigning approximate func-
tion (by identifying members of a known
superfamily), or selection of epitopes
for vaccine development (Nassal et al.,
2007). Medium resolution models, typi-
cally at the limit of detection of a structural
relationship using PSI-BLAST, and unre-
fined, may be used for a range of addi-
tional purposes, such as detecting likely
sites of protein-protein interactions (Kras-
ley et al., 2006), identifying the approxi-
mate role of disease-associated substitu-
tions (Ye et al., 2006), or assessing the
likely role of alternative splicing in protein
function (Wang et al., 2005). Higher reso-
lution models, derived from relationships
with better than about 30% sequence
identity or refined from lower resolution
starting models, add such uses as mole-
cule replacement in solving a crystal
structure (Qian et al., 2007), providing
a detailed interpretation of the impact of
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population SNPs on protein function
(Yue andMoult, 2006), identifying ortholo-
gous functional relationships, and in fa-
vorable cases, assigning detailed aspects
of molecular function (Murray and Honig,
2002). (Note that the latter application is
often not possible from an experimental
structure.) All three classes of model are
used to provide a more detailed structure
for molecular complexes obtained by
cryo-electronmicroscopy and other lower
resolution techniques (Chiu et al., 2002).
While there is no question than an exper-
imental structure is always the ideal, these
and other applications addressable with
models span many of the needs of most
biologists.
Because of the strong correspondence
between the level of sequence relation-
ship of two proteins and the similarity of
their structures, it is often possible to pro-
duce a useful model with very simple pro-
cedures—mapping the sequence of the
protein of interest onto the template
provided by a sequence relative. As out-
lined above, depending on the level of
sequence identity to a known structure,
these models are often already very use-
ful. They do have limitations both in accu-
racy and in the fraction of the structure
included, and these limitations increase
markedly with decreasing sequence relat-
edness. For this reason, much effort has
been devoted to developing more sophis-
ticated methods of comparative model-
ing, with the goal of approaching as close
to the correct structure as possible. The
Critical Assessment of Structure Predic-
tion (CASP) experiments have been mea-
suring the effectiveness of modeling
methods every two years since 1994.
While some of the results from the
1994 experiment were not impressive,
the accuracy and power of comparative
modeling techniques has improved be-
yond recognition in the intervening years
(Kryshtafovych et al., 2007; Moult, 2005).
The fraction of protein domains for
which at least a low resolution model
can be obtained has increased greatly,
partly because of the large amount se-
quence information now available for
building profiles and the greatly enhanced
availability of representative experimental
structures (lately mostly generated by
structural genomics activities), but also be-
cause new computational methods have
greatly increased sensitivity. In the mostrecent CASP, topologies were recognized
for all but two of the target domains with
known folds (Kopp et al., 2007). As well,
the quality of models at all resolutions
has increased dramatically. Three factors
contribute to this increase. First, fidelity of
aligning the sequence of interest onto
a template, a major factor in limiting over-
all accuracy, has improved steadily, and
in CASP7, 60% of template-based best
models had more residues correctly
aligned than could be deduced from a sin-
gle best template (Kryshtafovych et al.,
2007), implying near perfect alignment.
Second, all target residues are not usually
represented in a single available template.
Modeling of these missing regions, using
both alternative templates and template-
free methods, has improved steadily
over the CASPs, contributing most of the
additional aligned residues in the best
models. Third, in regions that are covered
by a template, the backbone conforma-
tion of target and template will not be
identical. Recently, methods of refining
starting models so they converge toward
the experimental structure have begun
to be impressively effective (see Figure 5
in Kryshtafovych et al., 2007 for some ex-
amples). Neither problem is completely
solved, but as a result of these advances,
the fraction of CASP targets containing
nontrivial added information beyond that
provided by a single template has in-
creased from an already impressive 65%
in 2002’s CASP5 to almost 80% in
2006’s CASP7 (Kryshtafovych et al.,
2007). Further, a recent report (Qian
et al., 2007) demonstrates that refinement
methods are now able to improve the ac-
curacy of structures derived from NMR.
One should not exaggerate the power of
the current methods—the results quoted
above are for the best models submitted
to CASP. Nevertheless, the impact on
model quality has already been very large,
and there is every sign the recent im-
provements will continue. Until recently
a legitimate criticism of model usefulness
was that no estimate of accuracy is avail-
able, and thus a user does not know what
to trust. In the most recent CASP experi-
ment this critical aspect of modeling was
an area of focus. It transpired that the
best methods are already usefully effec-
tive at assigning detailed accuracy (Coz-
zetto et al., 2007), although there is
certainly a great deal of room for improve-
ment. Still, here again there is every rea-Structure 16, January 20son to expect substantial further short-
term progress.
In summary, the PSI strategy of obtain-
ing experimental structures that maximize
the coverage of protein space in terms of
the quality and quantity of models is criti-
cal to addressing the structural needs of
the vast majority of molecular and cell
biologists. The models often do provide
the level of accuracy and detail required
to address the scientific questions of
interest, and modeling methods have
improved beyond recognition in the last
15 years and are likely to continue to
do so.
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As the central repository for all macro-
molecular structures, the Protein Data
Bank (PDB) started collaborating with
the worldwide structural genomics pro-
jects from their inception (Berman et al.,
2000, 2003). From the beginning, it was
clear that structural genomics, including
the U.S.-funded Protein Structure Initia-
tive (PSI), would change theways in which
we think about publishing and data shar-
ing. As time has gone on it is becoming
clear that these efforts will make a signifi-
cant impact on how we do structural
biology. By creating an appropriate infra-
structure in the form of a Knowledgebase,
the fruits of the PSI effort can enable
a new kind of biology.
Since 1989, it has become the norm to
submit coordinates as a condition for pub-
lishing articles describing structure deter-
minations (International Union of Crystal-
lography, 1989). For PSI projects, it has
been mandatory to deposit and release
the coordinate and structure factor data
within one month of completing a struc-
ture, prior to any journal publication. The
impact of this policy raises some interest-
ing questions. Would this mean that PSI
research could be no longer published in
standard journals? How would journal
publication practices change? Two things
have emerged so far. First, a PDB entry
can itself be thought of as a publication.
ThePDBnowassigns adigital object iden-
tifier (DOI) to every structure, and these
are beginning to appear as references in
published articles. Second, more than
600 papers describing the results of struc-
ture determinations have been authored
16 Structure 16, January 2008 ª2008 Elseviemodeling. Proc. Natl. Acad. Sci. USA 102,
18920–18925.
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at PSI centers—subsequent to data re-
lease—andmanymore are in the pipeline.
Whether or not this will become a trend for
non-PSI structures, which are typically re-
leasedafter journal publication, remains to
be seen.
An important aspect of the charter of
the PSI is the suggestion of a new para-
digm for the information sharing in sup-
port of the advancement of science. In
addition to sharing the results of structure
determinations, the PSI projects provide
the sequence aswell as information about
the status of each target under investiga-
tion. It is very unusual in conventional
structural biology for these types of data
to be made public in advance of publica-
tion of the structure. TargetDB (http://
targetdb.pdb.org) tracks status indicators
for each step in the structure determina-
tion pipeline (Chen et al., 2004). Along
with information such as protocols for
protein production, PepcDB (http://pepcdb.
pdb.org) provides the reasons why work on
a particular target has stopped (Kouranov
et al., 2006). The information in these
resources provides methods to facilitate
experimental design, not only for the PSI
projects but also for the biological com-
munity at large. Data sharing that includes
thedisclosure of sequences, tracking, and
protocol details in advance of publication
or deposition into the PDB and the early
release of coordinate and experimental
data is far ahead of current practices
in structural biology. This represents
a significant leap from where we were
25 years ago, when some investigators
worried about making their coordinates
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available to the rest of the research
community!
A review of the progress of the PSI
since it began in 2001 demonstrates that
it has been tremendously successful in
achieving the initial goals of selecting,
producing, and determining the struc-
tures of many novel proteins in a high
throughput manner. More than 2700
structures have been determined; most
remarkably, about half of these have
been determined in the two years since
the second phase, PSI-2, began. Of the
structures determined, more than 68%
are novel, meaning they have less than
a 30% sequence identity with those in
the PDB. Our understanding of structure
space has been transformed in that the
conservation of overall polypeptide chain
folds is greater than had been anti-
cipated. With the clever targeting of
structures for analysis, the coverage of
sequence space that can now be mod-
eled is ever-increasing.
In June 2007, I was selected to lead
the development of the PSI Structural
Genomics Knowledgebase (PSI_SGKB).
The idea was to make the products of
the PSI widely available to the broader
community of biologists. Although I was
very aware of the success of the initiative
with respect to the production of many
structures, I needed to investigate the
full scope of activities of the PSI centers
before accepting this new challenge. In
reviewing all of the PSI center progress
reports and websites, I discovered a
treasure trove. Indeed, the PSI projects
have done more than simply determine
